Macroprolactin on the Advia Centaur: experience with 409 patients over a three-year period

N F Jassam1, A Paterson, C Lippiatt

  • 1Department of Clinical Biochemistry, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, UK. nuthar.jassam@leedsth.nhs.uk

Abstract

Insights

Polyethylene glycol (PEG) precipitation is crucial for accurately diagnosing hyperprolactinaemia with assays like the Advia Centaur, which have low macroprolactin (MPRL) reactivity. This screening helps prevent misdiagnosis in patients with elevated prolactin levels.

Area of Science:

  • Clinical Chemistry
  • Endocrinology
  • Laboratory Medicine

Background:

  • Macroprolactin (MPRL) interferes with prolactin assays, potentially causing misdiagnosis and improper patient management.
  • Prolactin assay variability in MPRL detection necessitates careful analytical considerations.
  • The Advia Centaur assay shows low reactivity with MPRL, highlighting the need for specific diagnostic protocols.

Purpose of the Study:

  • To evaluate the necessity of polyethylene glycol (PEG) precipitation for hyperprolactinaemia analysis using the Advia Centaur assay.
  • To determine the prevalence of MPRL as a cause of hyperprolactinaemia in a clinical setting.
  • To assess the clinical significance of elevated monomeric prolactin in patients with MPRL.

Main Methods:

  • Analysis of 464 hyperprolactinaemic samples collected over three years.
  • Screening for MPRL using a PEG precipitation protocol.
  • Comparison of monomeric prolactin concentration post-PEG precipitation with a reference range.

Main Results:

  • MPRL accounted for 4% of hyperprolactinaemia cases (16/409) over the study period.
  • Nine individuals with MPRL also exhibited elevated monomeric prolactin levels.
  • The Advia Centaur assay demonstrated low reactivity with MPRL.

Conclusions:

  • PEG screening remains essential for prolactin assays with low MPRL reactivity, such as the Advia Centaur.
  • Local reference ranges for monomeric prolactin are recommended for accurate interpretation post-PEG precipitation.
  • Accurate MPRL detection is vital for appropriate hyperprolactinaemia diagnosis and management.

Related Concept Videos

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.